SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization

Increasing detection of small renal masses by imaging techniques entails the need for accurate discrimination between benign and malignant renal cell tumors (RCTs) as well as among malignant RCTs, owing to differential risk of progression through metastization. Although histone methylation has been...

Full description

Bibliographic Details
Main Authors: Maria João Ferreira, Ana Sílvia Pires-Luís, Márcia Vieira-Coimbra, Pedro Costa-Pinheiro, Luís Antunes, Paula C. Dias, Francisco Lobo, Jorge Oliveira, Céline S. Gonçalves, Bruno M. Costa, Rui Henrique, Carmen Jerónimo
Format: Article
Language:English
Published: Taylor & Francis Group 2017-12-01
Series:Epigenetics
Subjects:
biomarker
histone methyltransferase
kidney cancer
metastasis
prognosis
renal cell tumor
renal cell carcinoma
riox2
setdb2
Online Access:http://dx.doi.org/10.1080/15592294.2017.1385685

Internet

http://dx.doi.org/10.1080/15592294.2017.1385685

Similar Items